Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab

Rasheed, Afshan Asghar

Cd20 Expression and Effects on Outcome of Relapsed/
Refractory Diffuse Large B Cell Lymphoma after Treatment
with Rituximab [electronic resource] - Asian Pacific journal of cancer prevention : APJCP Feb 2018 - 331-335 p. digital

Publication Type: Journal Article

2476-762X

10.22034/APJCP.2018.19.2.331 doi


Adult
Aged
Aged, 80 and over
Antigens, CD20--metabolism
Antineoplastic Agents, Immunological--therapeutic use
Biomarkers, Tumor--metabolism
Drug Resistance, Neoplasm
Female
Follow-Up Studies
Humans
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Middle Aged
Neoplasm Recurrence, Local--diagnosis
Prognosis
Remission Induction
Retrospective Studies
Rituximab--therapeutic use
Survival Rate
Young Adult